Pharmacological and non-pharmacological treatment of hypertension in dialysis patients
| Autor: | Mehmet Ozkahya |
|---|---|
| Přispěvatelé: | Ege Üniversitesi |
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
hypertension medicine.drug_class medicine.medical_treatment Meeting Report Dialysis patients Internal medicine medicine Antihypertensive drug Intensive care medicine Non pharmacological Dialysis business.industry Captopril medicine.disease mortality Blood pressure Nephrology Cardiology antihypertensive drug dialysis Hemodialysis dry weight Hypervolemia business medicine.drug |
| Zdroj: | Kidney International Supplements |
| ISSN: | 2157-1716 2157-1724 |
| Popis: | WOS: 000327884500020 Hypertension is very common in dialysis patients. The most important cause of hypertension is hypervolemia. Fluid restriction and volume management with standard hemodialysis are effective strategies to achieve dry weight and blood pressure control without use of antihypertensive drugs. If the captopril test is positive, a renin-angiotensin system blocker should be started. The pre-dialysis blood pressure goal in hemodialysis patients should be < 140/90 mm Hg initially and < 130/80 mm Hg at 3-6 months of dialysis. Turkish Society of Hypertension and Renal Diseases Publication costs for this article were supported by the Turkish Society of Hypertension and Renal Diseases, a nonprofit national organization in Turkey. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|